Top compounds associated with response to TTLL10


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.04
mRNA JW-74 CTRPv2 pan-cancer AAC 0.092 0.04
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.077 0.04
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.074 0.04
mRNA thapsigargin gCSI pan-cancer AAC -0.12 0.04
mRNA dacarbazine CTRPv2 pan-cancer AAC 0.064 0.05
mRNA ML210 CTRPv2 pan-cancer AAC -0.066 0.05
mRNA NVP-231 CTRPv2 pan-cancer AAC 0.065 0.05
mRNA brivanib CTRPv2 pan-cancer AAC -0.071 0.05
mRNA JQ-1 CTRPv2 pan-cancer AAC 0.062 0.05
Download CSV